Yahoo Web Search

Search results

    • Merck to Acquire EyeBio for $1.3 Billion

      Morningstar· 2 days ago

      By Adriano Marchese Merck has agreed to acquire clinical-stage ophthalmology biotech company EyeBio for a $1.3 billion, the two companies said Wednesday. The Wall Street Journal ...